You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-mitotic

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting, Caloric Restriction Trial in Pozzilli (Caloric restriction, Caloric restriction without

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Caloric Restriction
  • Caloric restriction
  • Caloric restriction without cow's milk and gluten
  • Pozzilli, IS, Italy
    Neuromed - Istituto Neurologico Mediterraneo Pozzilli
Jul 26, 2022

Metastatic Triple Negative Breast Cancer Trial in Houston (L-NMMA, Docetaxel, Amlodipine)

Completed
  • Metastatic Triple Negative Breast Cancer
  • Houston, Texas
    Houston Methodist Hospital
Oct 12, 2021

Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Apr 23, 2022

Diagnostic Score for Encephalitis to Assess Risk of Autoimmune

Recruiting
  • Autoimmune Encephalitis
  • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
  • Clinical score of Granillo and al.
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

Technology Trial in Hong Kong (The anti-wandering system)

Not yet recruiting
  • Technology
  • The anti-wandering system
  • Hong Kong, Hong Kong
    Haven of Hope Residential Service for the Disabled
Mar 28, 2023

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022

Solid Tumors Trial in United States (SL-801)

Terminated
  • Solid Tumors
  • New Haven, Connecticut
  • +5 more
Jan 27, 2022

NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel

Recruiting
  • Non-small Cell Lung Cancer
  • TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
  • TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
  • Beijing, Beijing, China
  • +2 more
Jun 19, 2023

Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

Recruiting
  • Seasonal Allergic Rhinitis
  • LP-003 dose 1
  • +2 more
  • Beijing, Beijing, China
  • +16 more
Sep 18, 2023

Celiac Disease Trial in Spain

Recruiting
  • Celiac Disease
    • Terrassa, Barcelona, Spain
    • +5 more
    Aug 10, 2023

    Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)

    Not yet recruiting
    • Thyroid Diseases
    • +2 more
    • curcumin
    • Anti-inflammatory diet
    • Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of
      Golbon Sohrab
    Jul 27, 2023

    T- and B-Cell Subpopulations in Membranous Nephropathy

    Recruiting
    • Membranous Nephropathy
    • +2 more
      • Istanbul, Turkey
        Istanbul University
      May 31, 2023

      Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)

      Recruiting
      • Post-endodontic Pain
      • Cryotherapy
      • +2 more
      • Cairo, Egypt
        Ain Shams University
      Oct 13, 2023

      Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

      Not yet recruiting
      • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
      • +2 more
      • Biopsy
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 28, 2023

      Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

      Not yet recruiting
      • Refractory Cancer
      • +3 more
      • IMA402 (Phase Ia)
      • +2 more
      • Heidelberg, Baden-Wuerttemberg, Germany
      • +12 more
      Jul 14, 2023

      HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

      Recruiting
      • HER2-positive Gastric Cancer
      • Immunotherapy
      • Disitamab Vedotin combined with fruquintinib and Tislelizumab
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 8, 2023

      Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 5, 2023

      Wrinkle, Spot Pigmented, Lines Skin Trial in Clearwater (Nutraceutical Topical)

      Recruiting
      • Wrinkle
      • +2 more
      • Nutraceutical Topical
      • Clearwater, Florida
        Laser Scalp and Hair Center
      Feb 9, 2023

      Focal Laser Single Intravitreal Ranibizumab Retinal Artery

      Completed
      • Retinal Artery Macroaneurysm
      • Dual focal laser and intravitreal Ranibizumab injection
      • Cairo, Egypt
        Kasr alainy faculty of medicine
      Jan 29, 2023

      Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")

      Not yet recruiting
      • Ulcerative Colitis
      • "Mesalamine" and "alpha-lipoic acid"
      • "Mesalamine" and "Placebo"
      • (no location specified)
      Oct 5, 2023

      Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

      Recruiting
      • Macular Edema Due to Type 2 Diabetes Mellitus
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Feb 26, 2023

      Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

      Not yet recruiting
      • Muscle-Invasive Bladder Carcinoma
      • +2 more
      • Guangzhou, Guangdong, China
        Cancer Center, Sun Yat-sen University
      Aug 3, 2023

      Determination of Blood Tumor Cells

      Completed
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Abnormalities Cell Epithelial
        • Zurich, Switzerland
          University Hospital Zurich
        Jan 9, 2023

        Metabolic Syndrome Trial in Arifwala (Black Mulberry Fruit Powder)

        Not yet recruiting
        • Metabolic Syndrome
        • Black Mulberry Fruit Powder
        • Arifwala, Punjab, Pakistan
          THQ Hospital
        Jul 13, 2023